| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $191.2M | -2.3% |
| Gross Profit | $68.8M | +31.2% |
| R&D Expense | $20.6M | -4.3% |
| SG&A Expense | $17.2M | -16.8% |
| Operating Income | $1.7M | +104.7% |
| Pre-tax Income | -$13.7M | +69.8% |
| Income Tax | $689K | -22.1% |
| Net Income | $4.6M | +109.9% |
| EPS (Basic) | $0.10 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.6M | +426.6% |
| Accounts Receivable | $13.8M | -39.0% |
| Inventory | $13.6M | -40.7% |
| Current Assets | $72.9M | +25.2% |
| Total Assets | $100.0M | -17.9% |
| Current Liabilities | $63.5M | +13.5% |
| Total Liabilities | $112.9M | -49.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $33.5M | +367.8% |
| Capital Expenditures | $100K | -85.8% |
| Investing Cash Flow | $43.0M | +523.2% |
| Financing Cash Flow | -$38.8M | -1854.0% |
| Free Cash Flow | $33.4M | +417.2% |
| +102.3% |
| EPS (Diluted) | $0.10 | +102.3% |
| Stockholders' Equity |
| -$12.9M |
| +87.4% |